Role of an outpatient clinic in screening chronic complications of diabetes: A model for diabetes managed care

Journal of the Formosan Medical Association

Volumn 97, Issue 8, 1998, Pages 521-527

  Jiang, Yi Der ^a   Chuang, Lee Ming ^a   Wu, Huey Peir ^a   Tai, Tong Yuan ^a   Lin, Boniface J ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Annual screening; Diabetic complications; Taiwan

Indexed keywords

AGED; ARTICLE; COMPLICATION; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MODEL; NEUROPATHY; OUTPATIENT DEPARTMENT; RETINOPATHY; RISK FACTOR; SCREENING; TAIWAN;

ADULT; AGED; CHRONIC DISEASE; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; RISK FACTORS;

EID: 0031669506     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Richard P, Britz A, Carlsson P, et al: Metabolic control and complications over 3 years in patients with insulin-dependent diabetes (IDDM): the Stockholm diabetes intervention study (SDIS) J Intern Med 1990;280:511-7.
3. Dahl-Jorgensen K, Brinchmann-Hannsen O, Hannsen KF, et al: Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. BMJ 1986;293:1195-9.
4. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28: 103-17.
5. Abraira C, Colwell JA, Nuttall FQ, et al: VA Cooperative Study on Glycemic Control and Complications in type II diabetes (VA CSDM). Diabetes Care 1995; 18:1113-23.
6. Kornitzer M, Dramaix M, Sobolski J, et al: Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995;46:211-9.
7. Miettinen H, Haffner SM, Lehto S, et al: Retinopathy predicts coronary heart events in NIDDM patients. Diabetes Care 1996;19:1445-8.
8. Savage S, Estacio RO, Jeffers B, et al: Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996;19:1243-8.
9. Executive Yuan Health Department, ROC and Diabetes Association, ROC: A Desktop Guide for the Management of Non-Insulin Dependent Diabetes Mellitus (NIDDM). Taipei: Executive Yuan Health Department, 1993.
10. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997;20(Suppl 1):5-13.
11. Tseng FY: Quality of medical care for non-insulin-dependent diabetic patients in a community teaching hospital in Taiwan. J Formos Med Assoc 1996;95:414-6.
12. Peters AL, Legorreta AP, Ossorio RC, et al: Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care 1996;19:601-6.
13. Worrall G, Freake D, Kelland J, et al: Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines. J Fam Pract 1997;44:374-81.
14. Ho M, Marger M, Beart J, et al: Is the quality of diabetes care better in a diabetic clinic or in a general medicine clinic? Diabetes Care 1997;20:472-5.
15. Lawler FH, Vaviani N: Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract 1997;44:369-73.
16. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
17. American Diabetes Association: Screening for diabetic retinopathy. Diabetes Care 1997;20(Suppl 1):28-31.
18. Tai TY, Chuang LM, Tseng CH, et al: Microalbuminuria and diabetic complications in Chinese non-insulin-dependent diabetic patients: a prospective study. Diabetes Res Clin Pract 1990;9:59-63.
19. Alzaid AA: Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 1996;19:79-89.
20. Mogensen CE, Viberti GC, Peheim E, et al: Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997;20:1642-7.
21. American Diabetes Association: Diabetic nephropathy. Diabetes Care 1997;20(Suppl 1):24-7.
22. American Diabetes Association: Diabetic neuropathy. Diabetes Care 1996;19(Suppl 1):67-71.
23. American Diabetes Association: Standardized measures in diabetic neuropathy. Diabetes 1996;19(Suppl 1):72-92.
24. Holewski JJ, Stess RM, Graf PM, et al: Aesthesiometry: quantification of cutaneous pressure in diabetic peripheral neuropathy. J Rehab Res Develop 1988;25:1-10.
25. Thivolet C, Farkh JE, Petiot A, et al: Measuring vibration sensation with graduated tuning fork: Diabetes Care 1990;13:1077-80.
26. Pitei DL, Watkins PJ, Stevens MJ, et al: The value of the neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabetes Med 1994;11:872-6.
27. Nicolucci A, Cavaliere D, Scorpiglione N, et al: A comprehensive assessment of the avoidability of long term complications of diabetes. Diabetes Care 1996;19:927-33.
28. Collins VR, Dowse GK, Finch CF, et al: Prevalence and risk factors for micro-and macroalbuminuria in diabetic subjects and entire population in Nauru. Diabetes 1989; 38:1602-10.
29. Kasiske BL, Kalikl RSN, Ma JZ: Effect of antihypertensive therapy on the kidney in patients with diabetes: a metaregression analysis. Ann Intern Med 1993;118:129-38.
30. Maithiesen ER, Hommel E, Giese J, et al: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 1991;303:81-7.
31. Anonymous: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
32. UK Prospective Diabetes Study (UKPDS) X: Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycemia and hypertriglyceridemia. Diabetologia 1993;36:1021-9.
33. Hotta N: Symposium on treatment of diabetic complications. 1. Retinopathy. Intern Med 1997;36:136-8.
34. Toyota T, Satoh J: Symposium on treatment of diabetic complications. 2. Diabetic neuropathy. Intern Med 1997;36:139-41.
35. Kikkawa R: Symposium on treatment of diabetic complications. 3. The management of diabetic nephropathy. Intern Med 1997;36:141-2.
36. Yamada N: Symposium on treatment of diabetic complications. 4. Diabetes and atherosclerosis. Intern Med 1997;36:142-4.
37. Shiciri M. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications. Intern Med 1997;36:144-7.
38. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
39. Bennett PH, Haffner S, Kasiske BL, et al: Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kid Dis 1995;25:107-12.